InVivo Therapeutics taps UnitedHealth vet Stahl for 1st commercial chief
InVivo Therapeutics (NSDQ:NVIV) said yesterday it appointed ex-UnitedHealthcare Community Health Plan of Wisconsin CEO Pamela Stahl to the newly-formed position of chief commercial officer, effective September 14.
Stahl spent 10 years at UnitedHealthcare in multiple roles, eventually overseeing the largest Medicaid business in the state with benefits and services for over 160,000 residents. Prior to her time at UnitedHealthcare, Stahl served as veep of sales & commercial operations for Orphan Medical.
“We are delighted to be bringing such an experienced and seasoned leader to InVivo at this pivotal time in the company’s history. We are progressing through our clinical development program and it’s imperative that we further develop the market for the Neuro-Spinal Scaffold as we look toward commercialization. Pam brings three essential skills and experiences: reimbursement, building commercial organizations, and patient advocacy. She has decades of experience in the industry, having worked at all levels of a commercial organization, and I am confident she will be a tremendous asset to the company,” CEO Mark Perrin said in a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.